Connect with us

health

Nigeria Health Workers Recruitment gets Approval

Published

on

Nigeria health workers

Nigeria health workers recruitment gets approval as FG plans to hire 20,000 staff to strengthen hospitals and improve healthcare across the country

adron lemon friday

Nigeria health workers are set to receive a major boost as the Federal Government has approved the recruitment and deployment of more than 20,000 professionals across public hospitals in the country.

Also read: Nigerian Health System Collapsing, Experts Uncover $1bn Medical Tourism Crisis

Minister of Health and Social Welfare, Professor Ali Pate, made the announcement in Abuja during the launch of the Nigeria Strategic Directions for Nursing and Midwifery.

He explained that 60 per cent of those to be recruited will be nurses and midwives, who form the backbone of patient care in the nation’s hospitals.

Pate noted that the government’s decision forms part of a wider effort to close the gap between the number of available health workers and the growing demand for medical services.

“We are investing in our people because a strong health workforce is central to our nation’s well-being,” he said.

Under the ongoing Sector-Wide Approach (SWAP) reforms, the ministry has already retrained more than 69,000 frontline workers across all 36 states.

The minister added that President Bola Tinubu had granted waivers to fast-track the recruitment process, ensuring hospitals can quickly fill critical positions.

The newly launched five-year plan aims to strengthen training and education, improve career progression, expand leadership roles, and retain skilled professionals within Nigeria’s health system.

Chief of Staff to the President, Femi Gbajabiamila, who attended the event, described the policy as “a clear roadmap to elevate nursing and midwifery and strengthen Nigeria’s healthcare delivery.”

Permanent Secretary of the ministry, Daju Kachallom, highlighted the plan’s four key priorities: improving nursing education to meet global standards, ensuring fair compensation, empowering nurses to take on leadership roles, and promoting quality healthcare nationwide.

Registrar of the Nursing and Midwifery Council of Nigeria, Dr Ndagi Alhassan, revealed that the country now produces over 115,000 nurses annually, compared to just 23,000 in previous years.

However, he acknowledged that finding employment for many newly qualified professionals remains a challenge.

To address this, the government intends to collaborate with local communities to train and employ nurses who will serve in their hometowns — a move designed to curb unemployment and reduce migration abroad.

At the event, Professor Pate, Senator Banigo, and Rt. Hon. Femi Gbajabiamila were recognised as Ambassadors of the Nursing and Midwifery Profession for their contributions to the sector.

Also read: Nigerian Health Fraud Charges Spark Shocking $14bn Crackdown in United States

With this approval, Nigeria’s healthcare system takes a decisive step towards building a stronger, more sustainable workforce that can meet the needs of millions of citizens across the nation.

5 / 100 SEO Score

News

NAFDAC Finds 11,400 Cartons of Banned Chemicals

Published

on

NAFDAC has uncovered nearly 11,400 cartons of banned agrochemicals, including Paraquat products, in Kano warehouses, raising fresh concerns about food safety and regulatory enforcement

(more…)

adron lemon friday

70 / 100 SEO Score
Continue Reading

health

FCCPC Moves Against Producers Over Poorly Fortified Oil, Salt

Published

on

FCCPC orders producers to comply with food fortification standards after a survey found inadequately fortified vegetable oil and salt in Nigerian markets

(more…)

adron lemon friday

68 / 100 SEO Score
Continue Reading

health

UK Tests Five-Day Breast Cancer Radiotherapy in Major Trial

Published

on

The UK is testing five-day breast cancer radiotherapy in a major trial that could reduce hospital visits and treatment costs for patients

The United Kingdom has launched a major clinical trial involving more than 1,000 participants to determine whether breast cancer radiotherapy can be shortened from three weeks to five days without compromising its effectiveness in preventing the disease from returning.

Also read: Grey CEO Urges Africa to Ditch Dollar for Trade

adron lemon friday

The government-funded FAST-Forward Boost trial, being conducted at 39 hospitals across the UK, will investigate whether a shorter course of radiotherapy combined with an additional targeted dose, known as a boost, can provide effective treatment for patients following breast cancer surgery.

The UK Department of Health and Social Care announced the development on Friday, October 30, describing the study as part of efforts to improve cancer treatment and make care more convenient for patients.

Led by the Institute of Cancer Research in London and funded by the National Institute for Health and Care Research, the study aims to recruit 4,830 participants by 2028.

Those enrolled will be followed up for five years, with results expected in 2033.

If the approach proves successful, it could reduce the number of hospital visits required by patients, potentially saving them 10 journeys compared with the existing three-week treatment schedule.

The department said the shorter schedule could also reduce transport expenses and the time patients spend away from work and family.

It could additionally ease pressure on the National Health Service by freeing up radiotherapy capacity for other patients.

Health and Social Care Secretary Yvette Cooper said the trial reflected the country’s efforts to use medical research to improve cancer care.

“This trial shows how the UK is using our world beating research capabilities to pursue huge improvements and transformations in cancer treatment for patients,” she said.

Why the radiotherapy trial matters

Radiotherapy uses carefully targeted radiation to destroy cancer cells or prevent them from growing.

For many people with breast cancer, it is recommended after surgery to reduce the risk of the disease returning in the treated area.

A treatment boost involves delivering an additional dose of radiation to the area considered to have a higher risk of recurrence, usually the site where the tumour was removed.

The FAST-Forward Boost trial is examining how this additional treatment can be incorporated into a shorter schedule.

Reducing treatment from three weeks to five days could make a considerable difference to patients who must travel regularly to hospitals.

The impact may be particularly significant for people living far from specialist cancer centres, those with limited transport options and patients balancing treatment with employment or family responsibilities.

However, the trial is designed to establish whether the shorter approach is effective and safe for the patients being studied. Its results will be important in determining whether the treatment schedule can become a wider option in clinical practice.

UK expands breast cancer screening efforts

The announcement comes as the British government intensifies efforts to improve breast cancer screening, encourage early diagnosis and strengthen support for patients.

The Department of Health and Social Care said screening uptake among women receiving their first invitation had risen to 63.6 per cent, its highest level in a decade.

Despite the improvement, around four in 10 women invited for their first screening appointment still do not attend.

The government is also working with the National Institute for Health and Care Research and NHS England on studies examining how artificial intelligence could support the analysis of mammograms.

The technology is being explored as a way to assist the assessment of breast screening images, although its role and effectiveness must be established through appropriate research and clinical evaluation.

In addition, the government has partnered with breast cancer charity Breast Cancer Now for three years to help women recognise symptoms, find reliable information and access support after treatment.

Together, the initiatives reflect a broader approach to breast cancer care, combining screening, research into treatment improvements and support for people living with the disease.

Also read: Grey CEO Urges Africa to Ditch Dollar for Trade

For now, the five-day radiotherapy approach remains under investigation. With final results not expected until 2033, the FAST-Forward Boost trial will need to establish whether reducing treatment time can deliver comparable cancer control while maintaining patient safety.

65 / 100 SEO Score
Continue Reading

Trending News